Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05463341
Other study ID # NCH
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 9, 2022
Est. completion date January 31, 2026

Study information

Verified date April 2024
Source Nationwide Children's Hospital
Contact Nichole Michaels, PhD
Phone 614-355-5870
Email nichole.michaels@nationwidechildrens.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the study is to investigate the feasibility, acceptability, and associated benefits and harms of integrating FTS education and distribution into select Project DAWN sites in rural and urban communities in Ohio.


Description:

Purpose: Opioid-related fatalities are a leading cause of death in Ohio and nationally, with an increasing number of overdoses attributable to fentanyl. Rapid fentanyl test strips (FTS) test for the presence of some types of fentanyl in urine samples and are increasingly being used to check illicit drugs for fentanyl before they are used. FTS use is a promising harm reduction strategy and research shows when people who use drugs (PWUD) receive a positive result, they are more likely to perform overdose risk reduction behaviors. However, access to FTS is limited, and there are barriers to the adoption of this intervention in some communities. This study will investigate FTS distribution and education as a harm reduction strategy to prevent overdoses among PWUD. Study findings will contribute valuable information about the feasibility and acceptability of integrating FTS drug checking into Project DAWN sites in rural and urban communities in Ohio and help us achieve our long-term goal of reducing overdose deaths. Study Design: Project DAWN sites that volunteer to participate in the study will be randomly assigned to either the intervention or non-intervention arm of the study. Clients in the intervention arm of the study will receive: - One-on-one education on the purpose, benefits, and limitations of FTS testing - A brief 20-minute fentanyl test strip educational intervention, including a 2-3-minute video and hands-on demonstrations on how to use FTS - A supply of FTS upon enrollment and throughout the 2-year follow up period Clients in the non-intervention arm of the study will receive: • FTS education and a supply of FTS will be offered to participants in the non-intervention arm in the last year of the study Consent: Written documentation of informed consent will be obtained from all participants. Incentives: Participants will be compensated for their time with a gift cards for completing the baseline survey, the survey at 6-months, and each biweekly survey. Recruitment and Retention: Having a close partnership with Project DAWN sites will help us recruit and retain study participants. In addition to key informant interviews in year one and questionnaires in year five, the research team will survey coordinators quarterly to collect data on Project DAWN site and coordinator experiences, identify concerns, and take corrective actions. The investigators will also maintain regular communication with Project DAWN site coordinators when the study staff are onsite. The research team will handle all enrollment of study clients, delivery of the FTS intervention, and follow up with study participants. Project DAWN sites will be asked to provide a small space for the research team to enroll participants and provide the FTS intervention (if applicable). The sites will also be asked to refer potentially eligible individuals to the research team at times when they are on-site.


Recruitment information / eligibility

Status Recruiting
Enrollment 2400
Est. completion date January 31, 2026
Est. primary completion date January 31, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age 18 years or older - Visitor to a Project DAWN site in Ohio that does not currently distribute FTS and has agreed to participate in the study - Self-reported use of illicit drugs or prescription drugs purchased on the street within the past 6 months - Has a phone number or email address to allow for follow-up contact - Understands English (Based on the 2012-2016 American Community Survey, only 2.4% of Ohioans 5 years and older speak English less than "very well.") Exclusion Criteria: - None (must meet inclusion criteria)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Fentanyl Test Strips
A brief fentanyl test strip (FTS) education intervention will be given to participants at Project DAWN sites in the intervention arm after enrollment and collecting baseline data. It will be offered one-on-one with participants and will include the purpose, benefits, and limitations of FTS testing, and information on how to use FTS, interpret the results, what to do if the FTS is positive, and how to use FTS for different drug delivery methods. Participants will practice and demonstrate use of the FTS, and the short video on how to interpret the FTS will include an on-camera statement on the importance of testing for fentanyl. The video will be accessible to participants after study enrollment. Participants will be advised of the possibility of both false positive/negative results, and that the drugs may be mixed with other substances not detectable with FTS. Participants will be encouraged to practice other harm reduction strategies.

Locations

Country Name City State
United States Nationwide Children's Hospital Columbus Ohio

Sponsors (1)

Lead Sponsor Collaborator
Nationwide Children's Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Determine the perceived barriers and facilitating factors associated with incorporating FTS education and distribution in existing OEND programs in rural and urban counties. Key informant interviews with all site personnel and peer recovery mentors.
Quantitative Data/Process Measures:
# interested Project DAWN sites
# Project DAWN sites enrolled
# potential participants who request to enroll
# participants successfully enrolled
# people who receive FTS education and testing materials at baseline
# replacement FTS requested/distributed
total # FTS distributed
proportion of participants in the intervention arm who complete the biweekly surveys
proportion of participants who complete the 6-month follow-up questionnaire
Quarter 2 of Year 1
Primary Determine the perceived barriers and facilitating factors associated with incorporating FTS education and distribution in existing OEND programs in rural and urban counties. Follow up with intervention arm site personnel to gauge satisfaction with the program and identify any concerns.
Quantitative Data/Process Measures:
# interested Project DAWN sites
# Project DAWN sites enrolled
# potential participants who request to enroll
# participants successfully enrolled
# people who receive FTS education and testing materials at baseline
# replacement FTS requested/distributed
total # FTS distributed
proportion of participants in the intervention arm who complete the biweekly surveys
proportion of participants who complete the 6-month follow-up questionnaire
Quarter 3 of Year 5
Primary Determine the perceived barriers and facilitating factors associated with incorporating FTS education and distribution in existing OEND programs in rural and urban counties. Interview intervention arm site personnel to identify barriers and facilitating factors related to offering FTS education and distribution at OEND sites.
Quantitative Data/Process Measures:
# interested Project DAWN sites
# Project DAWN sites enrolled
# potential participants who request to enroll
# participants successfully enrolled
# people who receive FTS education and testing materials at baseline
# replacement FTS requested/distributed
total # FTS distributed
proportion of participants in the intervention arm who complete the biweekly surveys
proportion of participants who complete the 6-month follow-up questionnaire
Quarter 2 of Year 5
Primary Determine the perceived barriers and facilitating factors associated with incorporating FTS education and distribution in existing OEND programs in rural and urban counties. Interview intervention arm sites about the acceptability of the program.
Quantitative Data/Process Measures:
# interested Project DAWN sites
# Project DAWN sites enrolled
# potential participants who request to enroll
# participants successfully enrolled
# people who receive FTS education and testing materials at baseline
# replacement FTS requested/distributed
total # FTS distributed
proportion of participants in the intervention arm who complete the biweekly surveys
proportion of participants who complete the 6-month follow-up questionnaire
6-month follow-up
Primary Test the hypothesis that PWUD who receive FTS education and testing materials as part of an OEND program will have improved knowledge and self-efficacy regarding how to test drugs for fentanyl and strategies for lowering their risk of an opioid overdose. All participants (in both the intervention and non-intervention arms) will complete a questionnaire at enrollment (for the intervention group, prior to the intervention) and again at 6 months. Both questionnaires (baseline and 6 months) will include the same questions about the participant's knowledge of and self-efficacy in reducing their risk of an opioid overdose by using FTS (Appendix). Participants will be compensated for their time with gift cards for completing the questionnaires. 6-month follow-up
Primary Test the hypothesis that individuals who receive FTS education and testing materials as part of an OEND program will have a lower opioid overdose rate than individuals who receive OEND only ("usual practice"). Participants in the intervention arm will be contacted biweekly for 2 years and asked if they had an overdose in the past 2 weeks and, if so, what drug they were using at the time. Intervention arm participants will be asked to notify the study team when they receive a positive FTS result. Participants in the non-intervention arm will be contacted biweekly up to a maximum of 2 years after enrollment to ask if they had an overdose in the past 2 weeks and, if so, what drug they were using at the time. Fatal overdoses among participants in the intervention and non-intervention arms of the study will be identified by reviewing death certificates issued by the Ohio Department of Health quarterly starting in Year 2. Participating Project DAWN sites will be asked to advise the study team if they become aware of any fatal overdoses among clients who are enrolled in the study. Quarter 3 of Year 5
See also
  Status Clinical Trial Phase
Recruiting NCT02425657 - Fast Track Module Based Colonoscopy Training Programme for Surgical Trainees at North Jutland Surgical Departments
Completed NCT04253158 - Implementation of a Web-based Alcohol and Other Drug Prevention Intervention for Collegiate Student-athletes N/A
Active, not recruiting NCT04700930 - CBD Cigarettes Instead of Normal Cigarettes as Innovative Treatment for Schizophrenia N/A
Recruiting NCT05994703 - Assisting Smokers to Switch to an e-Cigarette by Accelerating Learning of Adaptive Habits Using D-cycloserine Phase 2
Completed NCT04210180 - Combination of E-cigarettes and Varenicline for Tobacco Harm Reduction Phase 2/Phase 3
Recruiting NCT06115746 - A Randomized Clinical Trial of a Novel Drug Education and Diversion Program (iDECIDE) for Middle and High School Students N/A
Recruiting NCT05493475 - Evaluation of a Novel Intervention to Prevent Polysubstance Overdoses Involving Illicit Stimulants N/A
Terminated NCT03675503 - Reducing Hospital Falls by Empowering Nurses to Provide Ambulatory Aids N/A
Completed NCT01249339 - In-vivo Extraction of Pb, Cd andTSNA From Swedish Snus Phase 1
Completed NCT01369693 - In-vivo Extraction of Pb, Cd and TSNA From Swedish Snus Phase 1
Completed NCT01838473 - In-vivo Extraction of Lead, Cadmium and Tobacco Specific Nitrosamines From Swedish 'Snus' in Regular Snus Users Phase 1
Completed NCT04250727 - Switching to Potential Reduced Exposure Products in Adult Smokers N/A
Completed NCT04650269 - Implementation of Onsite, Rapid ART Initiation Among People Who Inject Drugs Living With HIV at Syringe Services Program Phase 4
Completed NCT04268173 - Community-Based, Client-Centered Prevention Homes to Address the Rural Opioid Epidemic- Aim 3 Phase 3
Not yet recruiting NCT04351958 - An Augmented Reality Videogame for Alcohol Use Prevention and Harm Reduction in Teens N/A
Active, not recruiting NCT05404815 - Exposure to Plasticisers in the Neonatal Intensive Care Unit
Not yet recruiting NCT06429436 - Vending Machine Naloxone Distribution for Your Community (VENDY) Phase 4
Not yet recruiting NCT06372899 - Alternative Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers N/A
Recruiting NCT05516069 - Our Healthbox - Evaluating Interactive Dispensing Systems for Low-Barrier Access to HIV Testing and Harm Reduction. N/A
Completed NCT01130441 - Self-harming Behaviors Study of Adolescents in a Juvenile Detention House N/A